Development of platelets during steady state and inflammation

Journal of Leukocyte Biology

Volumn 101, Issue 5, 2017, Pages 1109-1117

  Müller Newen, Gerhard ^a   Stope, Matthias B ^b   Kraus, Thomas ^a   Ziegler, Patrick ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Emergency megakaryopoiesis; Hematopoietic progenitor cells; Interferon

Indexed keywords

CELL DIFFERENTIATION; CELL MATURATION; HEMATOPOIETIC STEM CELL; HUMAN; INFECTION; INFLAMMATION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEADY STATE; THROMBOCYTE; THROMBOCYTOSIS; ANIMAL; CELL LINEAGE; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

CYTOKINE; GATA1 PROTEIN, HUMAN; NFE2 PROTEIN, HUMAN; STAT PROTEIN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NF E2 P45 SUBUNIT;

ANIMALS; BLOOD PLATELETS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CYTOKINES; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION; MEGAKARYOCYTES; MICE; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT; PROTO-ONCOGENE PROTEINS C-ETS; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 85018455890     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1RU0916-391RR     Document Type: Review

References (143)

1. Herter, J. M., Rossaint, J., Zarbock, A. (2014) Platelets in inflammation and immunity. J. Thromb. Haemost. 12, 1764–1775.
2. Clark, S. R., Ma, A. C., Tavener, S. A., McDonald, B., Goodarzi, Z., Kelly, M. M., Patel, K. D., Chakrabarti, S., McAvoy, E., Sinclair, G. D., Keys, E. M., Allen-Vercoe, E., Devinney, R., Doig, C. J., Green, F. H., Kubes, P. (2007) Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463–469.
3. Kraemer, B.F., Campbell, R.A., Schwertz, H., Cody, M.J., Franks, Z., Tolley, N.D., Kahr, W.H., Lindemann, S., Seizer, P., Yost, C.C., Zimmerman, G.A., Weyrich, A.S. (2011)Novelanti-bacterialactivitiesofbeta-defensin1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog. 7, e1002355.
4. Riaz, A. H., Tasma, B. E., Woodman, M. E., Wooten, R. M., Worth, R. G. (2012) Human platelets efficiently kill IgG-opsonized E. coli. FEMS Immunol. Med. Microbiol. 65, 78–83.
5. Andonegui, G., Kerfoot, S. M., McNagny, K., Ebbert, K. V., Patel, K. D., Kubes, P. (2005) Platelets express functional Toll-like receptor-4. Blood 106, 2417–2423.
6. Jayachandran, M., Brunn, G. J., Karnicki, K., Miller, R. S., Owen, W. G., Miller, V. M. (2007) In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J. Appl. Physiol. (1985) 102, 429–433.
7. Venkata,C.,Kashyap,R.,Farmer,J.C.,Afessa,B.(2013) Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome. J. Intensive Care 1, 9.
8. Metcalf, D. (1999) Stem cells, pre-progenitor cells and lineage-committed cells: are our dogmas correct? Ann. N. Y. Acad. Sci. 872, 289–303, discussion 303–304.
9. Weissman, I. L. (2000) Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287, 1442–1446.
10. Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack, G. F., Shizuru, J. A., Weissman, I. L. (2003) Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21, 759–806.
11. Christensen, J. L., Weissman, I. L. (2001) Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98, 14541–14546.
12. + stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15, 659–669.
13. Kondo, M., Weissman, I. L., Akashi, K. (1997) Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661–672.
14. Akashi, K., Traver, D., Miyamoto, T., Weissman, I. L. (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193–197.
15. Galy, A., Travis, M., Cen, D., Chen, B. (1995) Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3, 459–473.
16. Hao, Q. L., Zhu, J., Price, M. A., Payne, K. J., Barsky, L. W., Crooks, G. M. (2001) Identification of a novel, human multilymphoid progenitor in cord blood. Blood 97, 3683–3690.
17. Manz, M. G., Miyamoto, T., Akashi, K., Weissman, I. L. (2002) Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl. Acad. Sci. USA 99, 11872–11877.
18. Muller-Sieburg, C. E., Cho, R. H., Karlsson, L., Huang, J. F., Sieburg, H. B. (2004) Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 103, 4111–4118.
19. Sanjuan-Pla, A., Macaulay, I. C., Jensen, C. T., Woll, P. S., Luis, T. C., Mead, A., Moore, S., Carella, C., Matsuoka, S., Bouriez Jones, T., Chowdhury, O., Stenson, L., Lutteropp, M., Green, J. C., Facchini, R., Boukarabila, H., Grover, A., Gambardella, A., Thongjuea, S., Carrelha, J., Tarrant, P., Atkinson, D., Clark, S. A., Nerlov, C., Jacobsen, S. E. (2013) Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature 502, 232–236.
20. Yamamoto, R., Morita, Y., Ooehara, J., Hamanaka, S., Onodera, M., Rudolph, K. L., Ema, H., Nakauchi, H. (2013) Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell 154, 1112–1126.
21. Nakorn,T.N.,Miyamoto,T.,Weissman,I.L.(2003)Characterizationofmouse clonogenic megakaryocyte progenitors. Proc.Natl.Acad.Sci.USA100, 205–210.
22. Pronk, C. J., Rossi, D. J., Mansson, R., Attema, J. L., Norddahl, G. L., Chan, C. K., Sigvardsson, M., Weissman, I. L., Bryder, D. (2007) Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell 1, 428–442.
23. Cobaleda, C., Busslinger, M. (2008) Developmental plasticity of lymphocytes. Curr. Opin. Immunol. 20, 139–148.
24. Nagai, Y., Garrett, K. P., Ohta, S., Bahrun, U., Kouro, T., Akira, S., Takatsu, K., Kincade, P. W. (2006) Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24, 801–812.
25. Haas, S., Hansson, J., Klimmeck, D., Loeffler, D., Velten, L., Uckelmann, H., Wurzer, S., Prendergast, A. M., Schnell, A., Hexel, K., Santarella-Mellwig, R., Blaszkiewicz,S.,Kuck,A.,Geiger,H.,Milsom,M.D.,Steinmetz,L.M., Schroeder,T.,Trumpp,A.,Krijgsveld,J.,Essers,M.A.(2015)Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors. Cell Stem Cell 17, 422–434.
26. Metcalf, D. (2008) Hematopoietic cytokines. Blood 111, 485–491.
27. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Silvennoinen, O. (1995) Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369–398.
28. Kaushansky, K. (2006) Lineage-specific hematopoietic growth factors. N. Engl. J. Med. 354, 2034–2045.
29. + bone marrow cells) are enriched with megakaryocytes expressing CD4. Blood 87, 1353–1360.
30. Dolzhanskiy, A., Basch, R. S., Karpatkin, S. (1997) The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3. Blood 89, 426–434.
31. + cells. Blood 91, 830–843.
32. Cortin, V., Garnier, A., Pineault, N., Lemieux, R., Boyer, L., Proulx, C. (2005) Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp. Hematol. 33, 1182–1191.
33. + cells. Stem Cells 24, 2877–2887.
34. + cells using a short two-phase culture system. J. Immunol. Methods 332, 82–91.
35. Tijssen, M. R., van Hennik, P. B., di Summa, F., Zwaginga, J. J., van der Schoot, C. E., Voermans, C. (2008) Transplantation of human peripheral blood CD34-positive cells in combination with ex vivo generated megakaryocytes results in fast platelet formation in NOD/ SCID mice. Leukemia 22, 203–208.
36. Yu, M., Cantor, A. B. (2012) Megakaryopoiesis and thrombopoiesis: an update on cytokines and lineage surface markers. Methods Mol. Biol. 788, 291–303.
37. De Sauvage, F. J., Carver-Moore, K., Luoh, S. M., Ryan, A., Dowd, M., Eaton, D. L., Moore, M. W. (1996) Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J. Exp. Med. 183, 651–656.
38. Goodnough, L. T., Kuter, D. J., McCullough, J., Slichter, S. J., DiPersio, J., Romo, J., Peterson, R., Smith, K. J., Raife, T., Tomita, D., Armstrong, S. (2001) Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood 98, 1346–1351.
39. Wagemaker, G., Neelis, K. J., Hartong, S. C., Wognum, A. W., Thomas, G. R., Fielder, P. J., Eaton, D. L. (1998) The efficacy of recombinant thrombopoietin in murine and nonhuman primate models for radiation-induced myelosuppression and stem cell transplantation. Stem Cells 16, 375–386.
40. Schumacher, A., Denecke, B., Braunschweig, T., Stahlschmidt, J., Ziegler, S., Brandenburg, L. O., Stope, M. B., Martincuks, A., Vogt, M., Gortz, D., Camporeale, A., Poli, V., Muller-Newen, G., Brummendorf, T. H., Ziegler, P. (2015) Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy. J. Hematol. Oncol. 8, 64.
41. MacVittie, T. J., Farese, A. M., Patchen, M. L., Myers, L. A. (1994) Therapeutic efficacy of recombinant interleukin-6 (IL-6) alone and combined with recombinant human IL-3 in a nonhuman primate model of high-dose, sublethal radiation-induced marrow aplasia. Blood 84, 2515–2522.
42. Wilde, M. I. and Faulds, D. (1998) Oprelvekin: a review of its pharmacology and therapeutic potential in chemotherapy-induced thrombocytopenia. BioDrugs 10, 159–171.
43. Tsuji-Takayama, K., Harashima, A., Tahata, H., Izumi, N., Nishida, Y., Namba, M., Okuda, Y., Ohta, T., Kurimoto, M. (1996) IFN-gamma in combination with IL-3 accelerates platelet recovery in mice with 5-fluorouracil-induced marrow aplasia. J. Interferon Cytokine Res. 16, 447–451.
44. Tsuji-Takayama, K., Tahata, H., Harashima, A., Nishida, Y., Izumi, N., Fukuda, S., Ohta, T., Kurimoto, M. (1996) Interferon-gamma enhances megakaryocyte colony-stimulating activity in murine bone marrow cells. J. Interferon Cytokine Res. 16, 701–708.
45. Wang, Q., Miyakawa, Y., Fox, N., Kaushansky, K. (2000) Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood 96, 2093–2099.
46. Beaulieu, L. M., Lin, E., Morin, K. M., Tanriverdi, K., Freedman, J. E. (2011) Regulatory effects of TLR2 on megakaryocytic cell function. Blood 117, 5963–5974.
47. D’Atri, L. P., Etulain, J., Rivadeneyra, L., Lapponi, M. J., Centurion, M., Cheng, K., Yin, H., Schattner, M. (2015) Expression and functionality of Toll-like receptor 3 in the megakaryocytic lineage. J. Thromb. Haemost. 13, 839–850.
48. Athanasiou, M., Clausen, P. A., Mavrothalassitis, G. J., Zhang, X. K., Watson, D. K., Blair, D. G. (1996) Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differ. 7, 1525–1534.
49. Wang, X., Crispino, J. D., Letting, D. L., Nakazawa, M., Poncz, M., Blobel, G. A. (2002) Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J. 21, 5225–5234.
50. Stachura, D. L., Chou, S. T., Weiss, M. J. (2006) Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1. Blood 107, 87–97.
51. Shivdasani, R. A., Fujiwara, Y., McDevitt, M. A., Orkin, S. H. (1997) A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16, 3965–3973.
52. Drachman, J. G., Sabath, D. F., Fox, N. E., Kaushansky, K. (1997) Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 89, 483–492.
53. Kirito, K., Osawa, M., Morita, H., Shimizu, R., Yamamoto, M., Oda, A., Fujita, H.,Tanaka,M.,Nakajima,K.,Miura,Y.,Ozawa,K.,Komatsu,N.(2002)A functional role of Stat3 in in vivo megakaryopoiesis. Blood 99, 3220–3227.
54. Ezumi, Y., Takayama, H., Okuma, M. (1995) Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett. 374, 48–52.
55. Pang, L., Xue, H. H., Szalai, G., Wang, X., Wang, Y., Watson, D. K., Leonard, W. J., Blobel, G. A., Poncz, M. (2006) Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins. Blood 108, 2198–2206.
56. Jenkins, B. J., Roberts, A. W., Najdovska, M., Grail, D., Ernst, M. (2005) The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis. Blood 105, 3512–3520.
57. Ezoe, S., Matsumura, I., Gale, K., Satoh, Y., Ishikawa, J., Mizuki, M., Takahashi, S., Minegishi, N., Nakajima, K., Yamamoto, M., Enver, T., Kanakura, Y. (2005) GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity. J. Biol. Chem. 280, 13163–13170.
58. Nichols, K. E., Crispino, J. D., Poncz, M., White, J. G., Orkin, S. H., Maris, J. M., Weiss, M. J. (2000) Familial dyserythropoietic anaemia and thrombocytopenia duetoaninheritedmutationinGATA1.Nat. Genet. 24, 266–270.
59. Freson, K., Devriendt, K., Matthijs, G., Van Hoof, A., De Vos, R., Thys, C., Minner, K., Hoylaerts, M. F., Vermylen, J., Van Geet, C. (2001) Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 98, 85–92.
60. He, D., Chen, T., Yang, M., Zhu, X., Wang, C., Cao, X., Cai, Z. (2011) Small Rab GTPase Rab7b promotes megakaryocytic differentiation by enhancing IL-6 production and STAT3-GATA-1 association. J. Mol. Med. (Berl.) 89, 137–150.
61. Gouilleux, F., Pallard, C., Dusanter-Fourt, I., Wakao, H., Haldosen, L. A., Norstedt, G., Levy, D., Groner, B. (1995) Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 14, 2005–2013.
62. 2/2 mice due to decreased survival of early erythroblasts. Blood 98, 3261–3273.
63. + cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis. Stem Cells 26, 1732–1742.
64. Wei, L., Laurence, A., O’Shea, J. J. (2008) New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation. Semin. Cell Dev. Biol. 19, 394–400.
65. Clarkson, R. W., Boland, M. P., Kritikou, E. A., Lee, J. M., Freeman, T. C., Tiffen, P. G., Watson, C. J. (2006) The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol. Endocrinol. 20, 675–685.
66. Grisouard, J., Shimizu, T., Duek, A., Kubovcakova, L., Hao-Shen, H., Dirnhofer, S., Skoda, R. C. (2015) Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN. Blood 125, 2131–2140.
67. Duek, A., Lundberg, P., Shimizu, T., Grisouard, J., Karow, A., Kubovcakova, L., Hao-Shen, H., Dirnhofer, S., Skoda, R. C. (2014) Loss of Stat1 decreases megakaryopoiesis and favors erythropoiesis in a JAK2-V617F-driven mouse model of MPNs. Blood 123, 3943–3950.
68. Huang, Z., Richmond, T. D., Muntean, A. G., Barber, D. L., Weiss, M. J., Crispino, J. D. (2007) STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. J. Clin. Invest. 117, 3890–3899.
69. Aundhakar, S. C., Mahajan, S. K., Mane, M. B., Lakhotiya, A. N. (2013) Reactive thrombocytosis leading to acute myocardial infarction. J. Assoc. Physicians India 61, 745–747.
70. Matsubara, K., Fukaya, T., Nigami, H., Harigaya, H., Hirata, T., Nozaki, H., Baba, K. (2004) Age-dependent changes in the incidence and etiology of childhood thrombocytosis. Acta Haematol. 111, 132–137.
71. Vlacha, V., Feketea, G. (2006) Thrombocytosis in pediatric patients is associated with severe lower respiratory tract inflammation. Arch. Med. Res. 37, 755–759.
72. Garoufi, A., Voutsioti, K., Tsapra, H., Karpathios, T., Zeis, P. M. (2001) Reactive thrombocytosis in children with upper urinary tract infections. Acta Paediatr. 90, 448–449.
73. Franchini, M., Lippi, G., Manzato, F. (2006) Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb. J. 4, 4.
74. Grewal, P. K., Uchiyama, S., Ditto, D., Varki, N., Le, D. T., Nizet, V., Marth, J. D. (2008) The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat. Med. 14, 648–655.
75. Kuter, D. J., Rosenberg, R. D. (1995) The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 85, 2720–2730.
76. Stoffel, R., Wiestner, A., Skoda, R. C. (1996) Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87, 567–573.
77. Grozovsky, R., Begonja, A. J., Liu, K., Visner, G., Hartwig, J. H., Falet, H. (2015) The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat. Med. 21, 47–54.
78. Kaser,A.,Brandacher,G.,Steurer,W.,Kaser,S.,Offner,F.A.,Zoller,H., Theurl, I., Widder, W., Molnar, C., Ludwiczek, O., Atkins, M. B., Mier, J. W., Tilg, H. (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98, 2720–2725.
79. Ingram, M., Coopersmith, A. (1969) Reticulated platelets following acute blood loss. Br. J. Haematol. 17, 225–229.
80. Ault, K. A., Rinder, H. M., Mitchell, J., Carmody, M. B., Vary, C. P., Hillman, R. S. (1992) The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am. J. Clin. Pathol. 98, 637–646.
81. Enz Hubert, R. M., Rodrigues, M. V., Andreguetto, B. D., Santos, T. M., de Fatima Pereira Gilberti, M., de Castro, V., Annichino-Bizzacchi, J. M., Dragosavac, D., Carvalho-Filho, M. A., De Paula, E. V. (2015) Association of the immature platelet fraction with sepsis diagnosis and severity. Sci. Rep. 5, 8019.
82. Kiel, M. J., Yilmaz, O. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., Morrison, S. J. (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109–1121.
83. Solar, G.P., Kerr, W.G., Zeigler, F.C., Hess, D., Donahue, C., de Sauvage, F.J., Eaton, D.L. (1998)Roleofc-mplinearlyhemat opoiesis. Blood 92, 4–10.
84. Matthews, W., Jordan, C. T., Wiegand, G. W., Pardoll, D., Lemischka, I. R. (1991) A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65, 1143–1152.
85. Ikuta, K., Weissman, I. L. (1992) Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. USA 89, 1502–1506.
86. McKinstry, W. J., Li, C. L., Rasko, J. E., Nicola, N. A., Johnson, G. R., Metcalf, D. (1997) Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89, 65–71.
87. Reddy, G. P., McAuliffe, C. I., Pang, L., Quesenberry, P. J., Bertoncello, I. (2002) Cytokine receptor repertoire and cytokine responsiveness of Ho(dull)/Rh(dull) stem cells with differing potentials for G1/S phase progression. Exp. Hematol. 30, 792–800.
88. Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., Melton, D. A. (2002) “Stemness”: transcriptional profiling of embryonic and adult stem cells. Science 298, 597–600.
89. Essers, M. A., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., Trumpp, A. (2009) IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458, 904–908.
90. Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I., Littman, D. R. (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595–599.
91. Schmid, M. A., Takizawa, H., Baumjohann, D. R., Saito, Y., Manz, M. G. (2011) Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood 118, 4829–4840.
92. Na Nakorn, T., Traver, D., Weissman, I. L., Akashi, K. (2002) Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 109, 1579–1585.
93. Fishley, B., Alexander, W. S. (2004) Thrombopoietin signalling in physiology and disease. Growth Factors 22, 151–155.
94. + cells, megakaryocytes, and platelets. Exp. Hematol. 30, 751–760.
95. Stohlawetz, P., Folman, C. C., von dem Borne, A. E., Pernerstorfer, T., Eichler, H. G., Panzer, S., Jilma, B. (1999) Effects of endotoxemia on thrombopoiesis in men. Thromb. Haemost. 81, 613–617.
96. Cuccurullo, A., Greco, E., Lupia, E., De Giuli, P., Bosco, O., Martin-Conte, E., Spatola, T., Turco, E., Montrucchio, G. (2016) Blockade of thrombopoietin reduces organ damage in experimental endotoxemia and polymicrobial sepsis. PLoS One 11, e0151088.
97. Ishiguro, A., Suzuki, Y., Mito, M., Shimbo, T., Matsubara, K., Kato, T., Miyazaki, H. (2002) Elevation of serum thrombopoietin precedes thrombocytosis in acute infections. Br. J. Haematol. 116, 612–618.
98. Yoshihara, H., Arai, F., Hosokawa, K., Hagiwara, T., Takubo, K., Nakamura, Y., Gomei, Y., Iwasaki, H., Matsuoka, S., Miyamoto, K., Miyazaki, H., Takahashi, T., Suda, T. (2007) Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1, 685–697.
99. Qian, H., Buza-Vidas, N., Hyland, C. D., Jensen, C. T., Antonchuk, J., Mansson, R., Thoren, L. A., Ekblom, M., Alexander, W. S., Jacobsen, S. E. (2007) Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 1, 671–684.
100. Fox, N., Priestley, G., Papayannopoulou, T., Kaushansky, K. (2002) Thrombopoietin expands hematopoietic stem cells after transplantation. J. Clin. Invest. 110, 389–394.
101. Kaushansky, K., Lok, S., Holly, R. D., Broudy, V. C., Lin, N., Bailey, M. C., Forstrom, J. W., Buddle, M. M., Oort, P. J., Hagen, F. S., et al. (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369, 568–571.
102. Debili, N., Wendling, F., Katz, A., Guichard, J., Breton-Gorius, J., Hunt, P., Vainchenker, W. (1995) The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86, 2516–2525.
103. Kuter, D. J., Goodnough, L. T., Romo, J., DiPersio, J., Peterson, R., Tomita, D., Sheridan, W., McCullough, J. (2001) Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood 98, 1339–1345.
104. Lennartsson, J., Ronnstrand, L. (2012) Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol. Rev. 92, 1619–1649.
105. Savas, A., Ince, S., Coskun, M., Durmaz, S., Yegin, O. (1998) Stem cell factor (SCF) levels in newborns. Am. J. Perinatol. 15, 427–429.
106. Seita, J., Ema, H., Ooehara, J., Yamazaki, S., Tadokoro, Y., Yamasaki, A., Eto, K., Takaki, S., Takatsu, K., Nakauchi, H. (2007) Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc. Natl. Acad. Sci. USA 104, 2349–2354.
107. Broudy, V. C., Lin, N. L., Kaushansky, K. (1995) Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85, 1719–1726.
108. Broughton, S. E., Dhagat, U., Hercus, T. R., Nero, T. L., Grimbaldeston, M. A., Bonder, C. S., Lopez, A. F., Parker, M. W. (2012) The GM-CSF/ IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling. Immunol. Rev. 250, 277–302.
109. Weber, G. F., Chousterman, B. G., He, S., Fenn, A. M., Nairz, M., Anzai, A., Brenner, T., Uhle, F., Iwamoto, Y., Robbins, C. S., Noiret, L., Maier, S. L., Zonnchen, T., Rahbari, N. N., Scholch, S., Klotzsche-von Ameln, A., Chavakis, T., Weitz, J., Hofer, S., Weigand, M. A., Nahrendorf, M., Weissleder, R., Swirski, F. K. (2015) Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science 347, 1260–1265.
110. Mach, N., Lantz, C. S., Galli, S. J., Reznikoff, G., Mihm, M., Small, C., Granstein, R., Beissert, S., Sadelain, M., Mulligan, R. C., Dranoff, G. (1998) Involvement of interleukin-3 in delayed-type hypersensitivity. Blood 91, 778–783.
111. Mazur, E. M., Cohen, J. L., Bogart, L., Mufson, R. A., Gesner, T. G., Yang, Y. C., Clark, S. C. (1988) Recombinant gibbon interleukin-3 stimulates megakaryocyte colony growth in vitro from human peripheral blood progenitor cells. J. Cell. Physiol. 136, 439–446.
112. D’Hondt, V., Weynants, P., Humblet, Y., Guillaume, T., Canon, J. L., Beauduin, M., Duprez, P., Longueville, J., Mull, R., Chatelain, C., et al. (1993) Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study. J. Clin. Oncol. 11, 2063–2071.
113. Schaper, F., Rose-John, S. (2015) Interleukin-6: biology, signaling and strategies of blockade. Cytokine Growth Factor Rev. 26, 475–487.
114. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Muller-Newen, G., Schaper, F. (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1–20.
115. Damas, P., Ledoux, D., Nys, M., Vrindts, Y., De Groote, D., Franchimont, P., Lamy, M. (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215, 356–362.
116. Michalevicz, R., Lifshitz, D., Revel, M. (1989) Interferon beta 2/ interleukin-6 and interleukin-3 synergize in stimulating proliferation of human early hematopoietic progenitor cells. Scanning Microsc. 3, 1143–1149, discussion 1149–1150.
117. Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., Kariyone, S., Hirano, T., Kishimoto, T., Takatsuki, F., Akiyama, Y. (1989) Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74, 1241–1244.
118. Johnstone, C. N., Chand, A., Putoczki, T. L., Ernst, M. (2015) Emerging roles for IL-11 signaling in cancer development and progression: focus on breast cancer. Cytokine Growth Factor Rev. 26, 489–498.
119. Ziegler, P., Boettcher, S., Takizawa, H., Manz, M. G., Brummendorf, T. H. (2016) LPS-stimulated human bone marrow stroma cells support myeloid cell development and progenitor cell maintenance. Ann. Hematol. 95, 173–178.
120. Einarsson, O., Geba, G. P., Zhu, Z., Landry, M., Elias, J. A. (1996) Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J. Clin. Invest. 97, 915–924.
121. Du, X. X., Scott, D., Yang, Z. X., Cooper, R., Xiao, X. L., Williams, D. A. (1995) Interleukin-11 stimulates multilineage progenitors, but not stem cells, in murine and human long-term marrow cultures. Blood 86, 128–134.
122. Weich, N. S., Fitzgerald, M., Wang, A., Calvetti, J., Yetz-Aldape, J., Neben, S., Turner, K. J. (2000) Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro. Blood 95, 503–509.
123. Du, X. X., Neben, T., Goldman, S., Williams, D. A. (1993) Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood 81, 27–34.
124. Hercus, T. R., Thomas, D., Guthridge, M. A., Ekert, P. G., King-Scott, J., Parker, M. W., Lopez, A. F. (2009) The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 114, 1289–1298.
125. Kantar, M., Kultursay, N., Kutukculer, N., Akisu, M., Cetingul, N., Caglayan, S. (2000) Plasma concentrations of granulocyte-macrophage colony-stimulating factor and interleukin-6 in septic and healthy preterms. Eur. J. Pediatr. 159, 156–157.
126. Socinski, M. A., Cannistra, S. A., Elias, A., Antman, K. H., Schnipper, L., Griffin, J. D. (1988) Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1, 1194–1198.
127. Stahl, C. P., Winton, E. F., Monroe, M. C., Haff, E., Holman, R. C., Myers, L., Liehl, E., Evatt, B. L. (1992) Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates. Blood 80, 2479–2485.
128. Akashi, K., Taniguchi, S., Teshima, T., Shibuya, T., Okamura, T., Harada, M., Niho, Y. (1990) Effect of N-methionine-free, bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in a primate model. Eur. J. Haematol. 44, 100–105.
129. Zheng, J., Umikawa, M., Cui, C., Li, J., Chen, X., Zhang, C., Huynh, H., Kang, X., Silvany, R., Wan, X., Ye, J., Canto, A. P., Chen, S. H., Wang, H. Y., Ward, E. S., Zhang, C. C. (2012) Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature 485, 656–660.
130. Zhu, P., Goh, Y. Y., Chin, H. F., Kersten, S., Tan, N. S. (2012) Angiopoietin-like 4: a decade of research. Biosci. Rep. 32, 211–219.
131. Platanias, L. C. (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375–386.
132. Hertzog, P. J., Williams, B. R. (2013) Fine tuning type I interferon responses. Cytokine Growth Factor Rev. 24, 217–225.
133. Biron, C. A. (1998) Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10, 383–390.
134. Pozzobon, T., Goldoni, G., Viola, A., Molon, B. (2016) CXCR4 signaling in health and disease. Immunol. Lett. 177, 6–15.
135. Fan, H., Wong, D., Ashton, S. H., Borg, K. T., Halushka, P. V., Cook, J. A. (2012) Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation. Inflammation 35, 130–137.
136. Sugiyama, T., Kohara, H., Noda, M., Nagasawa, T. (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977–988.
137. Hodohara, K., Fujii, N., Yamamoto, N., Kaushansky, K. (2000) Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood 95, 769–775.
138. Avecilla, S. T., Hattori, K., Heissig, B., Tejada, R., Liao, F., Shido, K., Jin, D. K., Dias, S., Zhang, F., Hartman, T. E., Hackett, N. R., Crystal, R. G., Witte, L., Hicklin, D. J., Bohlen, P., Eaton, D., Lyden, D., de Sauvage, F., Rafii, S. (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat. Med. 10, 64–71.
139. Mathieu, M. E., Saucourt, C., Mournetas, V., Gauthereau, X., Theze, N., Praloran, V., Thiebaud, P., Boeuf, H. (2012) LIF-dependent signaling: new pieces in the Lego. Stem Cell Rev. 8, 1–15.
140. Jansen, P. M., de Jong, I. W., Hart, M., Kim, K. J., Aarden, L. A., Hinshaw, L. B., Taylor, F. B., Jr., Hack, C. E. (1996) Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha. J. Immunol. 156, 4401–4407.
141. Shih, C. C., Hu, M. C., Hu, J., Weng, Y., Yazaki, P. J., Medeiros, J., Forman, S. J. (2000) A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells. Blood 95, 1957–1966.
142. Metcalf,D.,Hilton,D.,Nicola,N.A.(1991)Leukemiainhibitoryfactorcan potentiate murine megakaryocyte production in vitro. Blood 77, 2150–2153.
143. Mayer, P., Geissler, K., Ward, M., Metcalf, D. (1993) Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates. Blood 81, 3226–3233.